Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative

Hepatology

Volumn 49, Issue 4, 2009, Pages 1316-1325

  Lee, Sin Ae ^a,b   Ryu, Hyung Won ^c   Kim, Young Mee ^d   Choi, Suyong ^a,b   Lee, Mi Ji ^a,b   Kwak, Tae Kyoung ^a,b   Kim, Hyeon Jung ^a   Cho, Moonjae ^d   Park, Ki Hun ^c   Lee, Jun Weon ^a,b  

^a Stem Cell Research Center   (South Korea)

^b Seoul National University   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4' (4 TOLUENESULFONYLAMIDO) 4 HYDROXYCHALCONE; ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE; TETRASPANIN; UNCLASSIFIED DRUG; 4 (4 TOLUENESULFONYLAMIDO) 4 HYDROXYCHALCONE; 4-(4-TOLUENESULFONYLAMIDO)-4-HYDROXYCHALCONE; CHALCONE; CHALCONE DERIVATIVE; DRUG DERIVATIVE; MEMBRANE PROTEIN; SULFONAMIDE; TM4SF5 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHARMACOLOGICAL BLOCKING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; STRUCTURE ACTIVITY RELATION; ANIMAL; CARCINOGEN TESTING; CELL MOTION; CONTACT INHIBITION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GLYCOSYLATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHENOTYPE; PROTEIN DOMAIN; TUMOR CELL LINE;

ANIMALS; CARCINOGENICITY TESTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHALCONE; CHALCONES; CONTACT INHIBITION; GLYCOSYLATION; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICE; PHENOTYPE; POINT MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 65449132740     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22777     Document Type: Article

References (30)

1. Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett 2007;247: 1-25.
2. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003;94:575-581.
3. Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008;14:199-209.
4. Lee SA, Lee SY, Cho IH, Oh MA, Kang ES, Kim YB, et al. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 2008;118:1354-1366.
5. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 2007;39:2153-2160.
6. Wiesner S, Lange A, Fassler R. Local call: From integrins to actin assembly. Trends Cell Biol 2006;16:327-329.
7. Lee JW, Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 2004;17:188-202.
8. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008;582:2093-2101.
9. Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin proteins. Trends Biochem Sci 2003;28:106-112.
10. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 2004;167:1231-1240.
11. Wright MD, Ni J, Rudy GB. The L6 membrane proteins-a new fourtransmembrane superfamily. Protein Sci 2000;9:1594-1600.
12. Muller-Pillasch F, Wallrapp C, Lacher U, Friess H, Buchler M, Adler G, et al. Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene 1998;208:25-30.
13. Lee SY, Kim TY, Lee MS, Kim YB, Chung E, Kim S, et al. Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin α2 are regulated by serum treatment. Exp Cell Res 2006;312:2983-2999.
14. Ducki S. The development of chalcones as promising anticancer agents. IDrugs 2007;10:42-46.
15. Go M, Wu C, Liu X. Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem 2005;12:481-499.
16. Tamamori-Adachi M, Hayashida K, Nobori K, Omizu C, Yamada K, Sakamoto N, et al. Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. J Biol Chem 2004;279:50429-50436.
17. Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 1995;50:311-322.
18. Seo WD, Kim JH, Kang JE, Ryu HW, Curtis-Long MJ, Lee HS, et al. Sulfonamide chalcone as a new class of α-glucosidase inhibitors. Bioorg Med Chem Lett 2005;15:5514-5516.
19. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004;18:862-876.
20. Kumar SK, Hager E, Pettit C, Gurulingappa H, Davidson NE, Khan SR. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J Med Chem 2003;46:2813-2815.
21. Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumorhost interface. Semin Cell Dev Biol 2008;19:52-60.
22. Berditchevski F. Complexes of tetraspanins with integrins: More than meets the eye. J Cell Sci 2001;114:4143-4151.
23. Gesslbauer B, Rek A, Falsone F, Rajkovic E, Kungl AJ. Proteoglycanomics: ools to unravel the biological function of glycosaminoglycans. Proteomics 2007;7:2870-2880.
24. Leong TY, Leong AS. Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) 2005;7:5-15.
25. Caja L, Ortiz C, Bertran E, Murillo MM, Miro-Obradors MJ, Palacios E, et al. Differential intracellular signalling induced by TGF-β in rat adult hepatocytes and hepatoma cells: Implications in liver carcinogenesis. Cell Signal 2007;19:683-694.
26. Wice BM, Gordon JI. A tetraspan membrane glycoprotein produced in the human intestinal epithelium and liver that can regulate cell density-dependent proliferation. J Biol Chem 1995;270:21907-21918.
27. Adisakwattana S, Ngamrojanavanich N, Kalampakorn K, Tiravanit W, Roengsumran S, Yibchok-Anun S. Inhibitory activity of cyanidin-3-rutinoside on alpha-glucosidase. J Enzyme Inhib Med Chem 2004;19:313-316.
28. Romaniouk AV, Silva A, Feng J, Vijay IK. Synthesis of a novel photoaffinity derivative of 1-deoxynojirimycin for active site-directed labeling of glucosidase I. Glycobiology 2004;14:301-310.
29. Bernacki RJ, Niedbala MJ, Korytnyk W. Glycosidases in cancer and invasion. Cancer Metastasis Rev 1985;4:81-101.
30. Bertozzi CR, Kiessling LL. Chemical glycobiology. Science 2001;291: 2357-2364.